Kazunobu Sugawara

Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients

Keizo Yoshida, Kenichi Ito, Kazuhiro Sato et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2002 · 229 citations

Medicine, Pharmacology, Psychiatry +16

Monoamine oxidase: A gene polymorphism, tryptophan hydroxylase gene polymorphism and antidepressant response to fluvoxamine in Japanese patients with major depressive disorder

Keizo Yoshida, Shingo Naito, Hitoshi Takahashi et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2002 · 91 citations

Medicine, Pharmacology, Psychiatry +17

A kinetic and dynamic study of oral alprazolam with and without erythromycin in humans: In vivo evidence for the involvement of CYP3A4 in alprazolam metabolism*

Norio Yasui, Koichi Otani, Sunao Kaneko et al. · Clinical Pharmacology & Therapeutics · 1996 · 89 citations

Medicine, Pharmacokinetics, Pharmacology +14

Association between -1438G/A Promoter Polymorphism in the 5-HT<sub>2A</sub> Receptor Gene and Fluvoxamine Response in Japanese Patients with Major Depressive Disorder

Kazuhiro Sato, Keizo Yoshida, Hitoshi Takahashi et al. · Neuropsychobiology · 2002 · 77 citations

Medicine, Pharmacology, Psychiatry +17

Metabolic disposition of pantoprazole, a proton pump inhibitor, in relation to S-mephenytoin 4′-hydroxylation phenotype and genotype*

Μakoto Tanaka, Tadashi Ohkubo, Koichi Otani et al. · Clinical Pharmacology & Therapeutics · 1997 · 73 citations

Medicine, Pharmacokinetics, Pharmacology +14